These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25835097)

  • 1. [A breakthrough for the treatment of spasticity in multiple sclerosis].
    Lebrun C; Vermersch P
    Rev Neurol (Paris); 2015 Apr; 171(4):327-8. PubMed ID: 25835097
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of MS spasticity.
    Pozzilli C
    Eur Neurol; 2014; 71 Suppl 1():1-3. PubMed ID: 24457845
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabis based drug is licensed for spasticity in patients with MS.
    Kmietowicz Z
    BMJ; 2010 Jun; 340():c3363. PubMed ID: 20570870
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of spasticity management in multiple sclerosis. Evidence-based management strategies for spasticity treatment in multiple sclerosis.
    Haselkorn JK; Balsdon Richer C; Fry Welch D; Herndon RM; Johnson B; Little JW; Miller JR; Rosenberg JH; Seidle ME;
    J Spinal Cord Med; 2005; 28(2):167-99. PubMed ID: 15889701
    [No Abstract]   [Full Text] [Related]  

  • 5. THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.
    Sastre-Garriga J; Vila C; Clissold S; Montalban X
    Expert Rev Neurother; 2011 May; 11(5):627-37. PubMed ID: 21456949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
    Oreja-Guevara C
    Rev Neurol; 2012 Oct; 55(7):421-30. PubMed ID: 23011861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who benefits most from THC:CBD spray? Learning from clinical experience.
    Koehler J
    Eur Neurol; 2014; 71 Suppl 1():10-5. PubMed ID: 24457847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.
    Meuth SG; Vila C; Dechant KL
    Expert Rev Neurother; 2015; 15(8):909-18. PubMed ID: 26166264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spasticity: a common symptom of multiple sclerosis.
    Currie R
    Nurs Stand; 2001 May 2-8; 15(33):47-52; quiz 54-5. PubMed ID: 12216268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological treatment of pathological increases in muscle tonus].
    Reisner H
    Wien Med Wochenschr; 1978 Feb; 128(3):57-62. PubMed ID: 625998
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights into multiple sclerosis and advances in multiple sclerosis spasticity management.
    Gold R
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):1-2. PubMed ID: 24289835
    [No Abstract]   [Full Text] [Related]  

  • 12. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THC:CBD spray and MS spasticity symptoms: data from latest studies.
    Rekand T
    Eur Neurol; 2014; 71 Suppl 1():4-9. PubMed ID: 24457846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.
    Oreja-Guevara C
    Expert Rev Neurother; 2012 Apr; 12(4 Suppl):3-8. PubMed ID: 22509985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal cannabis extracts for the treatment of multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2004 Jul; 5(7):727-30. PubMed ID: 15298068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute unloaded leg cycling on spasticity in individuals with multiple sclerosis using anti-spastic medications.
    Motl RW; Snook EM; Hinkle ML
    Int J Neurosci; 2007 Jul; 117(7):895-901. PubMed ID: 17613103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.
    Koehler J; Amato MP; Oreja-Guevara C; Lycke J
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):61-6. PubMed ID: 24289846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the management of multiple sclerosis-related spasticity.
    Hartung HP
    Expert Rev Neurother; 2012 Apr; 12(4 Suppl):1. PubMed ID: 22509984
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M
    Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spasticity management in multiple sclerosis.
    Hughes C; Howard IM
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):593-604. PubMed ID: 24314678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.